15-72406686-T-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001080462.3(TMEM202):​c.422T>A​(p.Ile141Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000289 in 1,614,058 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00051 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

TMEM202
NM_001080462.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.587
Variant links:
Genes affected
TMEM202 (HGNC:33733): (transmembrane protein 202) Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016244113).
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMEM202NM_001080462.3 linkuse as main transcriptc.422T>A p.Ile141Asn missense_variant 3/5 ENST00000341689.4 NP_001073931.1 A6NGA9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMEM202ENST00000341689.4 linkuse as main transcriptc.422T>A p.Ile141Asn missense_variant 3/55 NM_001080462.3 ENSP00000340212.3 A6NGA9
TMEM202ENST00000649825.1 linkuse as main transcriptc.89T>A p.Ile30Asn missense_variant 3/5 ENSP00000497819.1 A0A3B3ITB0
TMEM202ENST00000567679.1 linkuse as main transcriptc.166T>A p.Ser56Thr missense_variant 2/32 ENSP00000456083.1 H3BUG9
TMEM202ENST00000568167.5 linkuse as main transcriptn.166T>A non_coding_transcript_exon_variant 2/42 ENSP00000457632.1 H3BUG9

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152198
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00353
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000326
AC:
82
AN:
251400
Hom.:
0
AF XY:
0.000265
AC XY:
36
AN XY:
135872
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000290
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000266
AC:
389
AN:
1461860
Hom.:
0
Cov.:
31
AF XY:
0.000248
AC XY:
180
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00107
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000297
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000506
AC:
77
AN:
152198
Hom.:
2
Cov.:
32
AF XY:
0.000686
AC XY:
51
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00353
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000236
Hom.:
0
Bravo
AF:
0.000631
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000296
AC:
36
EpiCase
AF:
0.000109
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 27, 2021The c.422T>A (p.I141N) alteration is located in exon 3 (coding exon 3) of the TMEM202 gene. This alteration results from a T to A substitution at nucleotide position 422, causing the isoleucine (I) at amino acid position 141 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
17
DANN
Benign
0.95
DEOGEN2
Benign
0.014
T;.
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.44
T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.016
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.1
N;.
REVEL
Benign
0.043
Sift
Uncertain
0.024
D;.
Sift4G
Uncertain
0.017
D;.
Polyphen
0.017
B;.
Vest4
0.55
MVP
0.16
MPC
0.19
ClinPred
0.017
T
GERP RS
1.8
Varity_R
0.061
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141474596; hg19: chr15-72699027; API